Skip to main content
Clinical Trials/NCT00757640
NCT00757640CompletedNot Applicable

The CHOLEGAS Study: Multicentric Randomized, Double-blinded, Controlled Trial of Gastrectomy Plus Prophylactic Cholecystectomy Versus Gastrectomy Only, in Adults Submitted to Gastric Cancer Surgery With Curative Intent.

Italian Research Group for Gastric Cancer2 sites in 1 country150 target enrollmentStarted: September 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
150
Locations
2
Primary Endpoint
Reduced biliary complications

Study Overview

Brief Summary

The patients will be divided into two groups: in the first group the patient will be submitted to prophylactic cholecystectomy during standard surgery for curable gastric cancer (subtotal or total gastrectomy), while in the second group will be submitted to standard gastric surgery only.

Detailed Description

The incidence of gallstones and gallbladder sludge is known to be higher in patients after gastrectomy than in general population. This higher incidence is probably related to surgical dissection of the vagus nerve branches and the anatomical gastrointestinal reconstruction. Therefore, some surgeons perform routine concomitant cholecystectomy during standard surgery for gastric malignancies. However, not all the patients who are diagnosed to have cholelithiasis after gastric cancer surgery will develop symptoms or require additional surgical treatments and a standard laparoscopic cholecystectomy is feasible even in those patients who underwent previous gastric surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing standard gastric surgery for cancer

Exclusion Criteria

  • gallbladder disease

Outcomes

Primary Outcomes

Reduced biliary complications

Time Frame: 5 years

Secondary Outcomes

  • Improved quality of life(5 years)

Investigators

Sponsor
Italian Research Group for Gastric Cancer
Sponsor Class
Network
Responsible Party
Principal Investigator
Principal Investigator

Bencini Lapo

Dr, PhD

Italian Research Group for Gastric Cancer

Study Sites (2)

Loading locations...

Similar Trials